Variable |
Non-CAD |
CAD |
P value |
N |
37(58.7%) |
26(41.3%) |
|
Age |
59.35±6.26 |
64.15±7.09 |
0.301 |
Male/female |
8(21.6%)/29(78.4%) |
13(50%)/13(50%) |
0.019 |
HbA1c |
7.73±2.16 |
7.11±1.23 |
0.155 |
HTN |
18(48.6%) |
17(65.4%) |
0.118 |
HLP |
20(54.1%) |
16(61.5%) |
0.371 |
SMOKING |
4(26.9%) |
7(10.8%) |
0.094 |
Neuropathy |
2(5.6%) |
3(12%) |
0.329 |
Retinopathy |
6(16.7%) |
4(15.4%) |
.584 |
Nephropathy |
6(16.7%) |
1(4%) |
0.131 |
PAD |
2(5.6%) |
4(15.4%) |
0.196 |
FH |
6(16.7%) |
3(11.5%) |
.427 |
B-blocker |
11(31.4%) |
17(53.8%) |
.078 |
ASA |
13(46%) |
11(44%) |
.798 |
ACEI |
17(53.1%) |
16(63.5%) |
.354 |
Statins |
21(60.0%) |
18(69.2%) |
.320 |
BMI |
28.08±5.99 |
28.3±4.13 |
.698 |
EF |
67.91\(\pm\ 9.29\)
|
63.11\(\pm\ 8.54\ \)
|
.033 |
EDV |
52.72\(\pm 3.41\ \ \)
|
68.52\(\pm 2.14\ \ \)
|
.097 |
ESV |
18.53\(\pm 2.23\)
|
29.35\(\pm\ 1.47\ \)
|
.089 |
LV dilated |
0 |
5(19.2%) |
|
RV |
0 |
4(15.4%) |
|
TID |
0 |
6(23.1%) |
|